TESCREAL hallucinations: Psychedelic and AI hype as inequality engines
TESCREAL hallucinations: Psychedelic and AI hype as inequality engines
Abstract
Background and Aims
While many scholars have called attention to similarities between the earlier SSRI hype and the ongoing hype for psychedelic medications, the rhetoric of psychedelic hype is tinged with utopian and esoteric aspirations that have no parallel in the discourse surrounding SSRIs or other antidepressants. This utopian discourse provides insight into the ways that global tech elites are instrumentalizing both psychedelics and artificial intelligence (AI) as tools in a broader world-building project that justifies increasing material inequality. If realized, this project would undermine the use of both tools for prosocial and pro-environmental outcomes.
Methods
My argument develops through rhetorical analysis of the ways that industry leaders envision the future of medicalized psychedelics in their public communications. I draw on examples from media interviews, blog posts, podcasts, and press releases to underscore the persuasive strategies and ideological commitments that are driving the movement to transform psychedelics into pharmaceutical medications.
Results
Counterfactual efforts to improve mental health by increasing inequality are widespread in the psychedelics industry. These efforts have been propelled by an elitist worldview that is widely-held in Silicon Valley. The backbone of this worldview is the TESCREAL bundle of ideologies, which describes an interrelated cluster of belief systems: transhumanism, Extropianism, singularitarianism, cosmism, Rationalism, Effective Altruism, and longtermism.
Conclusions
This article demonstrates that TESCREALism is a driving force in major segments of the psychedelic pharmaceutical industry, where it is influencing the design of extractive systems that directly contradict the field's world-healing aspirations. These findings contribute to a developing subfield of critical psychedelic studies, which interrogates the political and economic implications of psychedelic medicalization.
As it stands, both AI and psychedelics are bankrolled by financial elites who are seeking new ways to profit off of (and maintain) the status quo of power relations in society. Klein argues that the solutions to climate change are not elusive, as AI enthusiasts claim; rather, the known solutions are at odds with the status quo of capitalism, which profits off of the production of oil and “consumption-based models” for economic growth. A similar argument applies to the discourse on psychedelics: to actually fix the mental health “crisis,” we need to address the root cause of inequality by ensuring access to safe food, water, shelter, education, and healthcare. Since this would require systems change, economic elites are holding out for “magic bullet” solutions that can be deployed at scale to prop up—and develop new income streams for—the existing, dysfunctional socioeconomic system. The elite vision for psychedelics as individualized treatments for social problems is thus a symptom of the problem itself, as Klein describes of AI in relation to the climate: “The climate crisis is not, in fact, a mystery or a riddle we haven't yet solved…. We know what it would take, but it's not a quick fix—it's a paradigm shift. Waiting for…a more palatable and/or profitable answer is not a cure for this crisis, it's one more symptom of it."
